TREM2 and Alzheimer disease: Nguyen et al. established that one of the active clusters includes a subpopulation of CD163-positive microglia, which they named “amyloid-responsive microglia.” They determined that this cluster is enriched in APOE3/3 AD patients and is relatively depleted in cases with APOE4 carriers and TREM2 risk variants.